Drugs / DEXTRAN SULFATE SODIUM (5000 MW)
DEXTRAN SULFATE SODIUM (5000 MW)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03867851 | Feb 2021 → May 2024 | type 1 diabetes mellitus | TikoMed AB | Terminated | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DEXTRAN SULFATE SODIUM (5000 MW) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594555 ↗ |
| Known as | Dextran sulfate sodium (mw 5000) | ChEMBL registry synonym — accepted as the source's own label CHEMBL4594555 ↗ |
| Known as | IBsolvMIR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03867851 ↗ |
| Route | Intravenous | “administered intravenously at 18 mg/kg on day of transplantation and 3 mg/kg on post-operative days 1, 3, 6” NCT03867851 ↗ |